Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3β decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model.
Level 5 - mechanism / opinion, no new human data
Animal experiment (preclinical rodent model)
PubMed 22036080 · doi:10.1016/j.brainres.2011.09.056
What was done
Wistar rats received intracerebroventricular (ICV) streptozotocin (STZ; 3 mg/kg twice) to model sporadic Alzheimer's disease. Two weeks post-injection, short-term and long-term memory were evaluated using an autoshaping learning task following post-training administration of lithium (100 mg/kg), phenserine (1 mg/kg), memantine (5 mg/kg), or pioglitazone (30 mg/kg). Following behavioral testing, animals were sacrificed to measure phosphorylated GSK3β (p-GSK3β) and total GSK3β levels in the hippocampus and prefrontal cortex (PFC) using western blot.
What was found
ICV STZ treatment caused memory deficits and significantly reduced p-GSK3β levels in both the hippocampus and PFC without changing total GSK3β levels (specific numerical values and effect sizes not reported in the abstract). Memory impairment was reversed by all four tested drugs. Lithium, phenserine, and pioglitazone restored p-GSK3β levels in the hippocampus, whereas only lithium restored p-GSK3β in the PFC. Memantine had no effect on p-GSK3β levels in either brain region. Total GSK3β levels remained unchanged across all treatments.
Why it matters
The study compares multiple pharmacological classes in a rodent model of sporadic Alzheimer's disease, demonstrating that behavioral memory recovery can occur through pathways that either involve or bypass the restoration of phosphorylated GSK3β.
Limits
The findings are limited to an acute chemically induced rodent model, which does not capture the full complexity and chronicity of human Alzheimer's disease. The abstract does not provide group sizes (n), exact numerical measurements, or effect sizes. Long-term treatment outcomes and potential drug toxicities were not assessed.
Cited by
- supports Lithium improves insulin signaling in the brain.